Thousands are told their
suffering
is unexplained and untreatable.
We're funding the research that's never been done — understanding psychiatric drug withdrawal and comparing those who experience protracted withdrawal to those who don't, starting at the cellular level.
"Understanding withdrawal. Restoring health."
Become a founding donor
THE SCALE OF THE PROBLEM
What the data tells us - and what it doesn't
Psychiatric medication use is widespread. Research into what happens to the body after cessation is lagging far behind research into starting them.
16.5 % of U.S. adults
Adults
In 2020, 20.3% of adults had received any mental health treatment in the past 12 months, including 16.5% who had taken medication for their mental health, and 10.1% who received counseling or therapy from a mental health professionalÂ
Youth
8.3% of the youth
Psychotropic medication use among youth increased from 5.3% in 2001-2004 to 8.3% in 2017–March 2020  (adjusted time trend: 0.7 percentage points over 4 years; 95% CI: 0.3-1.1), with statistical increases observed among children and young adults, driven mainly by stimulants
Withdrawal Incidence
up to 56%Â
Systematic reviews estimate that up to 56% of people who attempt to stop antidepressants experience withdrawal effects; nearly half of those describe the effects as severe.
0
Comparitive studies
The same drug, the same taper, the same dose — and wildly different outcomes. Without head-to-head comparison studies, clinicians have insufficient ways to predict, prevent, or treat protracted symptoms.
months to years
Protracted Withdrawal
For a subset of people, withdrawal effects don't resolve in days or weeks as guidelines suggest — they persist for months or years, a phenomenon clinical guidance still doesn't fully account for.
1
Dedicated organization
We are the first organization dedicated to facilitating research into the biological mechanism of nervous system destabilization, starting from the mitochondria.